Home › Funds › Citadel Advisors › BVS
Citadel Advisors position in BVS
BIOVENTUS INC · Health Care
Latest position (Q2 2026)26.60K sh
Reported value held$251.10K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 15.90K | $226.00K | New |
| Q4 2021 | 25.55K | $370.00K | Add |
| Q1 2022 | 62.12K | $876.00K | Add |
| Q2 2022 | 139.16K | $950.00K | Add |
| Q3 2022 | 80.94K | $567.00K | Reduce |
| Q4 2022 | 48.12K | $125.60K | Reduce |
| Q2 2023 | 34.22K | $98.91K | New |
| Q3 2023 | 12.60K | $41.59K | Reduce |
| Q4 2023 | 92.91K | $489.61K | Add |
| Q1 2024 | 145.03K | $754.16K | Add |
| Q2 2024 | 586.76K | $3.37M | Add |
| Q3 2024 | 325.47K | $3.89M | Reduce |
| Q4 2024 | 51.93K | $545.26K | Reduce |
| Q1 2025 | 86.32K | $789.80K | Add |
| Q1 2025 | 86.32K | $789.80K | Add |
| Q2 2025 | 72.83K | $482.15K | Reduce |
| Q2 2025 | 72.83K | $482.15K | Reduce |
| Q3 2025 | 24.70K | $165.24K | Reduce |
| Q4 2025 | 110.03K | $818.59K | Add |
| Q1 2026 | 83.58K | $763.13K | Reduce |
| Q2 2026 | 26.60K | $251.10K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BVS
- BlackRock Inc 3.44M sh · $32.44M · Q2 2026
- Vanguard Group 2.98M sh · $22.21M · Q4 2025
- Royce & Associates 1.83M sh · $17.31M · Q2 2026
- Geode Capital Management 1.37M sh · $12.89M · Q2 2026
- Wellington Management Group 748.36K sh · $7.06M · Q2 2026
- Renaissance Technologies 736.00K sh · $6.95M · Q2 2026
- Goldman Sachs Group 652.37K sh · $6.16M · Q2 2026
- Fidelity Management & Research (FMR) 452.85K sh · $4.27M · Q2 2026
- Northern Trust Corp 443.82K sh · $4.19M · Q2 2026
- Prudential Financial 394.52K sh · $3.72M · Q2 2026
- Charles Schwab Investment Management 391.86K sh · $3.70M · Q2 2026
- AQR Capital Management 326.12K sh · $3.08M · Q2 2026